VOLITIONRX LTD Quarterly Selling and Marketing Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Volitionrx Ltd quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2016 to Q2 2024.
  • Volitionrx Ltd Selling and Marketing Expense for the quarter ending June 30, 2024 was $1.39M, a 16.9% decline year-over-year.
  • Volitionrx Ltd Selling and Marketing Expense for the twelve months ending June 30, 2024 was $6.53M, a 0.82% decline year-over-year.
  • Volitionrx Ltd annual Selling and Marketing Expense for 2023 was $6.84M, a 4.06% increase from 2022.
  • Volitionrx Ltd annual Selling and Marketing Expense for 2022 was $6.58M, a 76.6% increase from 2021.
  • Volitionrx Ltd annual Selling and Marketing Expense for 2021 was $3.72M, a 247% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.53M $1.39M -$283K -16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $6.81M $1.67M -$34.7K -2.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $6.84M $1.9M +$221K +13.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $6.62M $1.57M +$42.7K +2.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $6.58M $1.67M -$105K -5.92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $6.68M $1.71M +$108K +6.78% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $6.58M $1.68M -$220K -11.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $6.8M $1.52M +$688K +82.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $6.11M $1.77M +$1.21M +216% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.9M $1.6M +$1.17M +274% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.72M $1.9M +$1.56M +460% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.16M $837K +$592K +242% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.57M $562K +$346K +160% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.23M $427K +$153K +56% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1.07M $339K +$91.3K +36.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $982K $245K +$48.9K +25% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $933K $216K -$22.2K -9.34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $955K $274K -$10.3K -3.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $966K $248K -$63.3K -20.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $1.03M $196K -$63.7K -24.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.09M $238K +$2.76K +1.17% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.09M $284K -$79.9K -21.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.17M $311K +$137K +78.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $1.03M $259K +$73.5K +39.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $960K $235K +$28.3K +13.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $931K $364K +$94.7K +35.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $836K $174K +$76.1K +77.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 $760K $186K +$96.8K +109% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $664K $207K +$78.3K +60.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $585K $269K +$238K +745% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $348K $98.1K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $89K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $129K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $31.9K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.